Overview
Inscripta provides the Onyx benchtop platform for scalable CRISPR-based digital genome engineering, enabling massively parallel editing of single cells with automated workflows, consumables, software, and assays. The company also offers GenoScaler, a microbial strain engineering platform using CRISPR, AI, and machine learning for biomanufacturing applications in pharmaceuticals, agriculture, and chemicals. Headquartered in Boulder, Colorado, with offices in California and Denmark, Inscripta supports global research labs in accelerating biological discovery and strain optimization.
Frequently asked questions
- What genome engineering platforms does Inscripta offer?
- Inscripta offers the Onyx benchtop system for automated CRISPR-based editing and GenoScaler for high-throughput microbial strain engineering using CRISPR, AI, and machine learning.
- What industries does Inscripta serve?
- Inscripta serves pharmaceuticals, agriculture, chemicals, personal care, and biomanufacturing for sustainable ingredient production.
- Where are Inscripta's facilities located?
- Inscripta has facilities in Boulder, Colorado; San Diego and Pleasanton, California; and Copenhagen, Denmark, supporting global customers.